During the recent session, ProPhase Labs Inc (NASDAQ:PRPH)’s traded shares were 1.25 million, with the beta value of the company hitting -0.66. The 52-week high for the PRPH share is $7.48, that puts it down -1458.33 from that peak though still a striking 54.17% gain since the share price plummeted to a 52-week low of $0.22. The company’s market capitalization is $14.33M, and the average intraday trading volume over the past 10 days was 2.23 million shares, and the average trade volume was 9.92 million shares over the past three months.
ProPhase Labs Inc (PRPH) received a consensus recommendation of Hold from analysts. That translates to a mean rating of 1.00. PRPH has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 0 recommend a Buy rating for it.
ProPhase Labs Inc (NASDAQ:PRPH) trade information
ProPhase Labs Inc (PRPH) registered a -0.06% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -0.06% in intraday trading to $0.48, hitting a weekly high. The stock’s 5-day price performance is 23.44%, and it has moved by 9.00% in 30 days. Based on these gigs, the overall price performance for the year is -92.26%. The short interest in ProPhase Labs Inc (NASDAQ:PRPH) is 0.79 million shares and it means that shorts have 0.04 day(s) to cover.
The consensus price target of analysts on Wall Street is $14, which implies an increase of 96.57% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $14 and $14 respectively. As a result, PRPH is trading at a discount of -2816.67% off the target high and -2816.67% off the low.
PRPH Dividends
ProPhase Labs Inc is due to release its next quarterly earnings on 2024-Nov-12. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
ProPhase Labs Inc (NASDAQ:PRPH)’s Major holders
ProPhase Labs Inc insiders own 11.16% of total outstanding shares while institutional holders control 8.62%, with the float percentage being 9.70%. VANGUARD GROUP INC is the largest shareholder of the company, while 37.0 institutions own stock in it. As of 2024-06-30, the company held over 0.66 million shares (or 3.6351% of all shares), a total value of $2.74 million in shares.
The next largest institutional holding, with 0.22 million shares, is of RENAISSANCE TECHNOLOGIES LLC’s that is approximately 1.222% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $0.92 million.
Also, the Mutual Funds coming in first place with the largest holdings of ProPhase Labs Inc (PRPH) shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and Perritt Funds Inc-Perritt MicroCap Opportunities Fund. Data provided on Dec 31, 2024 indicates that VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund owns about 454.64 shares. This amounts to just over 1.90 percent of the company’s overall shares, with a $0.21 million market value. The same data shows that the other fund manager holds slightly less at 210.0, or about 0.88% of the stock, which is worth about $97692.0.
